Cat.#: ACPP-1245
| Despition | CRMP2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1098 | Synthetic Nanodisc Human CD133 Protein (AC1098) | 10 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1600 | Mouse IL 6 Protein, Sf9 (AC1600) | 2 µg | inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
| ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.